HP and systemic lupus erythematosus: Considering the absence of statistically significant variations in plasma zonulin level among both glucocorticoid-treated and non-glucocorticoid-treated groups, regardless of the concomitant medications, we can conclude that the medication used in patients with SLE does not appear to influence the integrity of the intestinal permeability, as indicated by plasma zonulin levels.